61-75 of 732
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiersDevelopments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Steven Paul, MD
Schizophrenia Care: Improving Social Cognition and Motivation
On the Frontlines of SchizophreniaSchizophrenia Care: Improving Social Cognition and Motivation
Michael Green, PhD
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiersExamining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NeuroFrontiersUnseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiersTransforming Schizophrenia Treatment: Advances in Medication and Therapy
Robert Walker, PharmD
Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiersAdvancing Schizophrenia Care: Challenges and Promising New Therapies
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
- advertisement
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiersSchizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiersBridging the Gap to Improved Schizophrenia Treatment Options
Recognizing and Addressing Burnout Among GI Providers
GI InsightsRecognizing and Addressing Burnout Among GI Providers
Peter Buch, MD, FACG, AGAF, FACP
Brian E. Lacy, MD, PhD
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
NeuroFrontiersThe Silent Struggle: Understanding ADHD's Impact on Girls and Women
Kathleen Nadeau, PhD
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
NeuroFrontiersAddressing ADHD in Women: A Guide to Diagnosis and Treatment
Ashley Baker, MSN, PMHNP
Kathleen Nadeau, PhD
Understanding the Cardiovascular Risks of ADHD Medications
NeuroFrontiersUnderstanding the Cardiovascular Risks of ADHD Medications
- advertisement
Understanding ADHD: Epidemiology, Impacts, and Management
NeuroFrontiersUnderstanding ADHD: Epidemiology, Impacts, and Management
ADHD in Older Adults: Key Diagnostic and Treatment Strategies
NeuroFrontiersADHD in Older Adults: Key Diagnostic and Treatment Strategies
Ashley Baker, MSN, PMHNP
David Goodman, MD, LFAPA
Differentiating the Diagnosis Between ADHD and Sleep Disorders
NeuroFrontiersDifferentiating the Diagnosis Between ADHD and Sleep Disorders
Ashley Baker, MSN, PMHNP
Stoni Johnston, APRN, MSN, PMHNP-BC
